Skip to main content
. Author manuscript; available in PMC: 2012 Nov 29.
Published in final edited form as: Circulation. 2011 Nov 29;124(22):2444–2455. doi: 10.1161/CIRCULATIONAHA.111.043943

Fig. 2.

Fig. 2

Clopidogrel dosing guided by platelet function assays helps achieve platelet inhibition in carriers of the CYP2C19*2 allele. Graphs show individuals who received additional clopidogrel loading doses (LD) if their post-clopidogrel platelet function remained elevated (according to the VASP assay), up to a total of 4 loading doses. Charts summarize the percentage of patients with elevated VASP index after the 1st and 4th loading doses (if needed). Adapted from20.

HHS Vulnerability Disclosure